Sasamori J[au] - Search Results

Year	Number of Results
1995	1
2000	1
2001	1
2006	1
2010	1
2011	1
2014	1
2015	1
2018	1
2022	0

1

Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury.

Dodo K, Shimizu T, Sasamori J, Aihara K, Terayama N, Nakao S, Iuchi K, Takahashi M, Sodeoka M. Dodo K, et al. Among authors: sasamori j. ACS Med Chem Lett. 2018 Jan 29;9(3):182-187. doi: 10.1021/acsmedchemlett.7b00454. eCollection 2018 Mar 8. ACS Med Chem Lett. 2018. PMID: 29541357 Free PMC article.

2

Effects of 2-Octynyladenosine (YT-146) on Mitochondrial Function in Ischemic/Reperfused Rat Hearts.

Sasamori J, Abe Y, Marunouchi T, Manome Y, Uchibori T, Tanonaka K. Sasamori J, et al. Biol Pharm Bull. 2015;38(12):1946-53. doi: 10.1248/bpb.b15-00629. Biol Pharm Bull. 2015. PMID: 26632185 Free article.

3

Cardioprotective effects of 2-octynyladenosine (YT-146) in ischemic/reperfused rat hearts.

Sasamori J, Aihara K, Uchibori T, Takahashi A, Takeo S, Tanonaka K. Sasamori J, et al. J Cardiovasc Pharmacol. 2011 Feb;57(2):166-73. doi: 10.1097/FJC.0b013e318201c264. J Cardiovasc Pharmacol. 2011. PMID: 21052018

4

The cardioprotective effects of novel Na+/H+ exchanger inhibitor TY-51924 on ischemia/reperfusion injury.

Sasamori J, Hasegawa T, Takaya A, Watanabe Y, Tanaka M, Ogino Y, Chiba T, Aihara K. Sasamori J, et al. J Cardiovasc Pharmacol. 2014 Apr;63(4):351-9. doi: 10.1097/FJC.0000000000000055. J Cardiovasc Pharmacol. 2014. PMID: 24336011

5

Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist.

Murakami A, Takasugi H, Ohnuma S, Koide Y, Sakurai A, Takeda S, Hasegawa T, Sasamori J, Konno T, Hayashi K, Watanabe Y, Mori K, Sato Y, Takahashi A, Mochizuki N, Takakura N. Murakami A, et al. Among authors: sasamori j. Mol Pharmacol. 2010 Apr;77(4):704-13. doi: 10.1124/mol.109.061481. Epub 2010 Jan 22. Mol Pharmacol. 2010. PMID: 20097776

6

Cardioprotective effect of TY-12533, a novel Na(+)/H(+) exchange inhibitor, on ischemia/reperfusion injury.

Aihara K, Hisa H, Sato T, Yoneyama F, Sasamori J, Yamaguchi F, Yoneyama S, Mizuno Y, Takahashi A, Nagai A, Kimura T, Kogi K, Satoh S. Aihara K, et al. Among authors: sasamori j. Eur J Pharmacol. 2000 Sep 15;404(1-2):221-9. doi: 10.1016/s0014-2999(00)00613-0. Eur J Pharmacol. 2000. PMID: 10980282

7

Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146).

Sasamori J, Aihara K, Yoneyama F, Sato I, Kogi K, Takeo S. Sasamori J, et al. J Cardiovasc Pharmacol. 2006 Apr;47(4):614-20. doi: 10.1097/01.fjc.0000211739.40336.c5. J Cardiovasc Pharmacol. 2006. PMID: 16680077

8

TY-12533, a novel Na(+)/H(+) exchange inhibitor, prevents myocardial stunning in dogs.

Aihara K, Hisa H, Sasamori J, Yoneyama F, Yamaguchi F, Satoh I, Satoh S. Aihara K, et al. Among authors: sasamori j. Eur J Pharmacol. 2001 May 4;419(1):93-7. doi: 10.1016/s0014-2999(01)00952-9. Eur J Pharmacol. 2001. PMID: 11348635

9

Structural modification of DNA by a DNA-binding motif SPKK: detection of changes in base-pair hydrogen bonding and base stacking by UV resonance Raman spectroscopy.

Takeuchi H, Sasamori J. Takeuchi H, et al. Among authors: sasamori j. Biopolymers. 1995 Apr;35(4):359-67. doi: 10.1002/bip.360350403. Biopolymers. 1995. PMID: 7711276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results